Protein glycation: measurement and clinical relevance.

This review of protein glycation deals with the biochemical background of glycated blood proteins, their methods of determination and their clinical significance. General reaction principles for determination of glycated proteins are discussed with special emphasis on the determination of glycated serum proteins in the clinical laboratory. Binding methods like boronate affinity, immunoassay, phenylhydrazine binding and ion exchange chromatography leave the analyte intact, whereas chemical methods like strong or mild hydrolysis or reduction in alkaline medium (fructosamine assay) results in destruction of the glycated protein. As most reactions are nonstoichiometric (except ion exchange chromatography and periodate oxidation), varying results are obtained from laboratory to laboratory. Up to now boronate affinity chromatography, mild hydrolysis yielding hydroxymethylfurfural and the fructosamine assay have been mostly used for determination of glycated serum proteins. The fructosamine assay appears to be most practical, because it is quick, economic and precise, but it suffers from unspecific side reactions. Although other methods like immunoassays or boronate ester formation in solution appear promising, there is currently no commercially available assay for the economic, precise and accurate determination of glycated serum protein. The clinical relevance of glycated serum protein determination is difficult to evaluate because the assays are based on different reaction principles and hence yield variable results. Nevertheless, the following conclusion may be drawn from the reports now available. i) The possibility that glycated serum proteins may discriminate better than glycated haemoglobin between "normal" and "diabetic" is still controversial. ii) Glycated serum proteins are formed faster than glycated haemoglobin, reflecting the changes in glycaemia for shorter periods of time (medium-term control). iii) It has not been yet established, using large cohorts, whether the glycated serum proteins allow the detection or exclusion of diabetes. iv) Determination of glycated serum proteins should not be considered as a substitute for the determination of glycated haemoglobin, but rather as a complementary determination, leading to the improved laboratory control of the diabetic patient.

[1]  E. Schleicher,et al.  Specific Quantitation by HPLC of Protein (Lysine) Bound Glucose in Human Serum Albumin and Other Glycosylated Proteins , 1981, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[2]  P. Dunn,et al.  Laboratory assessment of a commercial kit for measuring fructosamine in serum. , 1987, Clinical chemistry.

[3]  M. P. Cohen Diabetes and Protein Glycosylation , 1986, Springer New York.

[4]  R. Bassette,et al.  Detection of Intermediate Compounds in the Early Stages of Browning Reaction in Milk Products , 1959 .

[5]  E. Schleicher,et al.  Clinical Utility of Nonenzymatically Glycosylated Blood Proteins as an Index of Glucose Control , 1984, Diabetes Care.

[6]  C G Fraser,et al.  Assay of serum fructosamine that minimizes standardization and matrix problems: use to assess components of biological variation. , 1987, Clinical chemistry.

[7]  P. Gallop,et al.  Structural heterogeneity of human hemoglobin A due to nonenzymatic glycosylation. , 1979, The Journal of biological chemistry.

[8]  E. Schleicher,et al.  Quantitation of lysine-bound glucose of normal and diabetic erythrocyte membranes by HPLC analysis of furosine [ epsilon-N(L-furoylmethyl)-L-lysine]. , 1981, Biochemical and biophysical research communications.

[9]  G. Hughes,et al.  Synthesis and quantitation of glucitollysine, a glycosylated amino acid elevated in proteins from diabetics. , 1982, Analytical biochemistry.

[10]  O. Wieland,et al.  Increased Glycosylation of Serum Albumin in Diabetes Mellitus , 1980, Diabetes.

[11]  A. Gottschalk Some biochemically relevant properties of N-substituted fructosamines derived from amino-acids and N-arylglucosylamines. , 1952, The Biochemical journal.

[12]  E. Schleicher,et al.  Kinetic analysis of glycation as a tool for assessing the half-life of proteins. , 1986, Biochimica et biophysica acta.

[13]  P. Metcalf,et al.  Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus. , 1983, British medical journal.

[14]  D A Armbruster,et al.  Fructosamine: structure, analysis, and clinical usefulness. , 1987, Clinical chemistry.

[15]  J. Baker,et al.  Serum fructosamine concentrations in patients with type II (non-insulin-dependent) diabetes mellitus during changes in management. , 1984, British medical journal.

[16]  W. Endres,et al.  Glycated Haemoglobin and Glycated Albumin: Evaluation of Different Methods in Diabetic Control , 1984 .

[17]  K. Winterhalter,et al.  In vitro synthesis of hemoglobin AIc , 1976, FEBS letters.

[18]  J. Baker,et al.  Use of protein-based standards in automated colorimetric determinations of fructosamine in serum. , 1985, Clinical chemistry.

[19]  P. Metcalf,et al.  Relationship between albumin and fructosamine concentration in diabetic and non-diabetic sera. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[20]  F. Weygand,et al.  Die Amadori‐Umlagerung , 1937 .

[21]  O. Wieland,et al.  Improvement of the thiobarbituric acid assay for serum glycosylprotein determination. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[22]  J. Baynes,et al.  13C NMR investigation of nonenzymatic glucosylation of protein. Model studies using RNase A. , 1983, The Journal of biological chemistry.

[23]  J. MacDonald,et al.  Quantification of nonenzymically glycated albumin and total serum protein by affinity chromatography. , 1984, Clinical chemistry.

[24]  J. Hodge,et al.  The Amadori rearrangement. , 1955, Advances in carbohydrate chemistry.

[25]  R. Flückiger,et al.  Evaluation of the fructosamine test for the measurement of plasma protein glycation , 1987, Diabetologia.

[26]  A. Acharya,et al.  Amadori rearrangement of glyceraldehyde-hemoglobin Schiff base adducts. A new procedure for the determination of ketoamine adducts in proteins. , 1980, The Journal of biological chemistry.

[27]  G. Ghiggeri,et al.  Characterisation of the phenylhydrazone derivatives of "glycated albumin" purified from diabetic sera. , 1986, Carbohydrate research.

[28]  E. Schleicher,et al.  ε-Amino-Lysine-Bound Glucose in Human Tissues Obtained at Autopsy: Increase in Diabetes Mellitus , 1982, Diabetes.

[29]  E. Diamandis,et al.  An automated "high-pressure" liquid-chromatographic assay for hemoglobin A1c. , 1984, Clinical chemistry.

[30]  V. Monnier,et al.  Accelerated age-related browning of human collagen in diabetes mellitus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Metcalf,et al.  Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[32]  Paul J Thornalley,et al.  Inhibitory effect of superoxide dismutase on fructosamine assay. , 1987, Clinical chemistry.

[33]  A. Cerami,et al.  Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.

[34]  E. Schleicher,et al.  Is serum fructosamine assay specific for determination of glycated serum protein? , 1988, Clinical chemistry.

[35]  R. Flückiger,et al.  Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. , 1986, The Journal of biological chemistry.

[36]  J. Jeppsson,et al.  Clinical utility of serum fructosamine in diabetes mellitus compared with hemoglobin A1c. , 1988, Clinica chimica acta; international journal of clinical chemistry.

[37]  B. Gould,et al.  A Sensitive Method for the Measurement of Glycosylated Plasma Proteins Using Affinity Chromatography , 1984, Annals of clinical biochemistry.

[38]  Andrew J. Bannister,et al.  Separation of glycosylated haemoglobins using immobilized phenylboronic acid. Effect of ligand concentration, column operating conditions, and comparison with ion-exchange and isoelectric-focusing. , 1983, The Biochemical journal.

[39]  K. Miedema,et al.  Glycosylated Haemoglobins: Biochemical Evaluation and Clinical Utility , 1984, Annals of clinical biochemistry.

[40]  P. Higgins,et al.  Kinetic analysis of the nonenzymatic glycosylation of hemoglobin. , 1981, The Journal of biological chemistry.

[41]  A. Cerami,et al.  Measurement of Glycosylated Amino Acids and Peptides from Urine of Diabetic Patients Using Affinity Chromatography , 1980, Diabetes.

[42]  K. Shima,et al.  High-performance liquid chromatographic assay of serum glycated albumin , 1988, Diabetologia.

[43]  C. Seynaeve,et al.  Influence of variations in albumin or total-protein concentration on serum fructosamine concentration. , 1986, Clinical chemistry.

[44]  H. Borsook,et al.  Fructose-amino acids in liver: stimuli of amino acid incorporation in vitro. , 1955, The Journal of biological chemistry.

[45]  E. Schleicher,et al.  Non‐enzymatic glycosylation of human serum lipoproteins Elevated ϵ‐lysine glycosylated low density lipoprotein in diabetic patients , 1981, FEBS letters.

[46]  R. Krohn,et al.  Preparation and Use of a Boronic Acid Affinity Support for Separation and Quantitation of Glycosylated Hemoglobins , 1981 .

[47]  D. Willey,et al.  Glycosylated haemoglobin and plasma glycoprotein assays by affinity chromatography , 1984, Diabetologia.